 |
3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione hydrochloride |
|---|---|
| Trade Name | |
| Orphan Indication | Diffuse Large B-cell Lymphoma |
| EU Market Approval | EU |
| EU Designation Date | 2016-06-27 00:00:00 |
| Sponsor | Celgene Europe Limited |
| |
3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione hydrochloride |
|---|---|
| Trade Name | |
| Orphan Indication | Diffuse Large B-cell Lymphoma |
| EU Market Approval | EU |
| EU Designation Date | 2016-06-27 00:00:00 |
| Sponsor | Celgene Europe Limited |